Loading...

APC anti-mouse IFN-γ Antibody APC anti-mouse IFN-γ Antibody

Pricing & Availability
Clone
XMG1.2 (See other available formats)
Regulatory Status
RUO
Other Names
Interferon-γ, Immune interferon, Type II interferon, T cell interferon, Macrophage-activating factor (MAF)
Isotype
Rat IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
XMG1dot2_APC_032808
PMA/Ionomycin-stimulated (6hrs) C57BL/6 mouse splenocytes stained with XMG1.2 APC and B220 (RA3-6B2) PE
  • XMG1dot2_APC_032808
    PMA/Ionomycin-stimulated (6hrs) C57BL/6 mouse splenocytes stained with XMG1.2 APC and B220 (RA3-6B2) PE
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
505810 100 µg NOK1089
Check Availability


Need larger quantities of this item?
Request Bulk Quote
505809 25 µg NOK363
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

IFN-γ is a potent multifunctional cytokine which is secreted primarily by activated NK cells and T cells. Originally characterized based on anti-viral activities, IFN-γ also exerts anti-proliferative, immunoregulatory, and proinflammatory activities. IFN-γ can upregulate MHC class I and II antigen expression by antigen-presenting cells.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
E. coli-expressed, recombinant mouse IFN-γ
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The IFN-γ antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

ICFC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

ELISA1-4,11,14 or ELISPOT5 Detection: The biotinylated XMG1.2 antibody is useful as a detection antibody for a sandwich ELISA or ELISPOT assay, when used in conjunction with purified R4-6A2 antibody (Cat. No. 505702/505706) as the capture antibody and recombinant mouse IFN-γ (Cat. No. 575309) as the standard.
ELISA or ELISPOT Capture: The purified XMG1.2 antibody is useful as a capture antibody for a sandwich ELISA or ELISPOT assay, when used in conjunction with biotinylated R4-6A2 antibody (Cat. No. 505704) as the detection antibody and recombinant mouse IFN-γ (Cat. No. 575309) as the standard. The LEAF™ purified antibody is suggested for ELISPOT capture (Cat. No. 505812).
Flow Cytometry7,8,12,13,16: The fluorochrome-labeled XMG1.2 antibody is useful for intracellular immunofluorescent staining and flow cytometric analysis to identify IFN-γ-producing cells within mixed cell populations.
Neutralization1-3,9,10: The XMG1.2 antibody can neutralize the bioactivity of natural or recombinant IFN-γ. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for neutralization of mouse IFN-γ bioactivity in vivo and in vitro (Cat. No. 505812). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 505834) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).
Additional reported applications (for the relevant formats) include: Western blotting, immunohistochemical staining of frozen tissue sections6,22,23, and immunocytochemistry.
Note: For testing mouse IFN-γ in serum, plasma or supernatant, BioLegend's ELISA Max™ Sets (Cat. No. 430801 to 430806) are specially developed and recommended.

Application References
  1. Abrams J, et al. 1992. Immunol. Rev. 127:5. (ELISA, Neut)
  2. Sander B, et al. 1993. J. Immunol. Meth. 166:201. (ELISA, Neut)
  3. Abrams J, et al. 1995. Curr. Prot. Immunol. John Wiley and Sons, New York. Unit 6.20. (ELISA, Neut)
  4. Yang X, et al. 1993. J. Immunoassay 14:129. (ELISA)
  5. Klinman D, et al. 1994. Curr. Prot. Immunol. John Wiley and Sons, New York. Unit 6.19. (ELISPOT)
  6. Sander B, et al. 1991. Immunol. Rev. 119:65. (IHC)
  7. Ferrick D, et al. 1995. Nature 373:255. (FC)
  8. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  9. Peterson KE, et al. 2000. J. Virol. 74:5363. (Neut)
  10. DeKrey GK, et al. 1998. Infect. Immun. 66:827. (Neut)
  11. Dzhagalov I, et al. 2007. J. Immunol. 178:2113. (ELISA)
  12. Lawson BR, et al. 2007. J. Immunol. 178:5366. (FC)
  13. Lee JW, et al. 2006. Nature Immunol. 8:181. (FC) PubMed
  14. Xu G, et al. 2007. J. Immunol. 179:5358. (ELISA) PubMed
  15. Montfort M, et al.2004. J. Immunol. 173:4084. PubMed
  16. Haring JS, et al. 2008. J. Immunol. 180:2855. (FC) PubMed
  17. Jordan JM, et al. 2008. Infect Immun. 76:3717. PubMed
  18. Tonkin DR, et al. 2008. J. Immunol. 181:4516. PubMed
  19. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  20. Cui Y, et al. 2009. Invest. Ophth. Vis. Sci. 50:5811. (FC) PubMed
  21. Mykkanen OT, et al. 2014. PLoS One. 9:114790. PubMed
  22. Yokogawa M, et al. 2013. Mol. Carcinog. 52:760. (IHC)
  23. Mottram PL, et al. 1998. J Immunol. 161:602. (IHC)
Product Citations
  1. Cignarella F et al. 2018. Cell metabolism. 27(6):1222-1235 . PubMed
  2. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  3. Chinta KC et al. 2018. Cell reports. 25(7):1938-1952 . PubMed
  4. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  5. Zheng X, et al. 2019. PLoS Pathog. 15:e1008036. PubMed
  6. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  7. Hudson WH, et al. 2020. Immunity. 51(6):1043-1058.e4.. PubMed
  8. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  9. Oliver AJ, et al. 2020. Oncoimmunology. 9:1802979. PubMed
  10. Zhou R, et al. 2022. EBioMedicine. 75:103762. PubMed
  11. Zheng J, et al. 2022. Front Pharmacol. 13:866228. PubMed
  12. Tian WJ, et al. 2021. Clin Exp Pharmacol Physiol. 48:902. PubMed
  13. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  14. Xue G, et al. 2021. Cancer Cell. 39:1610. PubMed
  15. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  16. Stone ET, et al. 2022. Cell Rep. 38:110388. PubMed
  17. Guttman O, et al. 2022. J Cell Biol. 221: . PubMed
  18. Qu L, et al. 2022. Cell. 185:1728. PubMed
  19. Grebinoski S, et al. 2022. Nat Immunol. 23:868. PubMed
  20. Guo X, et al. 2022. Invest Ophthalmol Vis Sci. 63:12. PubMed
  21. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  22. Gary EN, et al. 2022. Cell Rep Med. 3:100693. PubMed
  23. Chen C, et al. 2022. Sci Adv. 8:eabo4363. PubMed
  24. Zhang Z, et al. 2022. Mol Nutr Food Res. 66:e2200300. PubMed
  25. Balood M, et al. 2022. Nature. 611:405. PubMed
  26. Zhu M, et al. 2022. Front Immunol. 13:1019248. PubMed
  27. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  28. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  29. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  30. Liu P, et al. 2023. Clin Immunol. 246:109212. PubMed
  31. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  32. Xiao J, et al. 2023. J Clin Invest. 133: . PubMed
  33. Kulkarni R, et al. 2023. Life Sci Alliance. 6: . PubMed
  34. Cheng H, et al. 2023. Nat Metab. 5:314. PubMed
  35. Kemna J, et al. 2023. Nat Immunol. 24:414. PubMed
  36. Vijver SV, et al. 2023. Front Immunol. 13:1100730. PubMed
  37. Drijvers JM, et al. 2021. Cancer Immunol Res. 9:184. PubMed
  38. Jiang L, et al. 2021. Nano Today. 36:. PubMed
  39. Tao X, et al. 2022. J Exp Med. 219:. PubMed
  40. McCafferty S, et al. 2022. Mol Ther. 30:2968. PubMed
  41. Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed
  42. Du J, et al. 2022. Sci Immunol. 7:eabo5407. PubMed
  43. Wang Z, et al. 2022. J Control Release. 349:929. PubMed
  44. Konjar S, et al. 2022. Proc Natl Acad Sci U S A. 119:e2202144119. PubMed
  45. Barsheshet Y, et al. 2022. Int J Mol Sci. 23:. PubMed
  46. Shi X, et al. 2023. iScience. 26:106143. PubMed
  47. Tursi NJ, et al. 2023. Front Immunol. 14:1072810. PubMed
  48. Cheng MI, et al. 2023. Nat Immunol. 24:780. PubMed
  49. Latour YL, et al. 2023. Gut Microbes. 15:2192623. PubMed
  50. Mackin S, et al. 2023. Nat Microbiol. 8:569. PubMed
  51. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  52. Fiedler T, et al. 2023. J Neuroinflammation. 20:100. PubMed
  53. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  54. Seo YB, et al. 2023. Int J Mol Sci. 24:. PubMed
  55. Wang X, et al. 2023. Nat Commun. 14:3440. PubMed
  56. Bergot AS, et al. 2020. J Immunol. 204:1787. PubMed
  57. Quispe Calla N, et al. 2016. Sci Rep. 6:37723. PubMed
  58. Harsha Krovi S, et al. 2020. Nat Commun. 4.790277778. PubMed
  59. Cella M, et al. 2019. Nat Immunol. 1.513888889. PubMed
  60. Xie A et al. 2017. Endocrinology. 158(10):3140-3151 . PubMed
  61. Vacca M, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01462. PubMed
  62. Yang N, et al. 2022. NPJ Vaccines. 7:120. PubMed
  63. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  64. Suresh R, et al. 2020. J Immunother Cancer. 8:. PubMed
  65. Hamilton JAG, et al. 2021. Aging Cell. 20:e13309. PubMed
  66. Du C, et al. 2016. Nat Commun. 7: 11120. PubMed
  67. Yang C, et al. 2018. J Immunol. 200:1316. PubMed
  68. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  69. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  70. Turner JA, et al. 2020. Immunity. 53:1202. PubMed
  71. Wabitsch S, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1166. PubMed
  72. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  73. Muthumani K, et al. 2015. Sci Transl Med. 7: 301ra132. PubMed
  74. Laroche-Lefebvre C, et al. 2016. J Immunol. 197: 3618 - 3627. PubMed
  75. Sanchez-Felipe L, et al. 2021. Nature. 590:320. PubMed
  76. Seo YB, et al. 2021. Vaccines (Basel). 9: . PubMed
  77. Burrack AL, et al. 2019. Cell Rep. 28:2140. PubMed
  78. Li Y, et al. 2020. Cell Rep. 30:1753. PubMed
  79. Ron–Harel N, et al. 2019. Cell Rep. 28:3011. PubMed
  80. Chow MT et al. 2019. Immunity. 50(6):1498-1512 . PubMed
  81. Lu J, et al. 2018. ACS Nano. 12:11041. PubMed
  82. Diao L, et al. 2022. iScience. 25:105511. PubMed
  83. Guo Q, et al. 2021. Front Cardiovasc Med. 8:633212. PubMed
  84. Gu M, et al. 2021. Nat Immunol. 22:193. PubMed
  85. Yang X, et al. 2021. Front Pharmacol. 12:771046. PubMed
  86. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  87. Klarquist J, et al. 2021. Cell Rep. 36:109591. PubMed
  88. Fitzgerald AA, et al. 2021. J Immunother Cancer. 9:. PubMed
  89. Wabitsch S, et al. 2021. STAR Protoc. 2:100517. PubMed
  90. Oda SK, et al. 2020. J Exp Med. 217: . PubMed
  91. Devalaraja S, et al. 2020. Cell. 1098:180. PubMed
  92. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  93. Zhao Y, et al. 2015. PLoS One. 10: 0134797. PubMed
  94. Ogawa C et al. 2018. Cell reports. 25(1):19-28 . PubMed
  95. Qi X, et al. 2019. Nat Commun. 10:2141. PubMed
  96. Matsuoka S, et al. 2019. Haematologica. 105:226. PubMed
  97. Saini V, et al. 2020. Nat Commun. 0.845138889. PubMed
  98. Chaurasiya S, et al. 2020. Oncoimmunology. 9:1729300. PubMed
  99. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  100. Konrath KM, et al. 2022. Cell Rep. 38:110318. PubMed
  101. Nagaoka M, et al. 2014. J Immunol. 193:2812. PubMed
  102. Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed
  103. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  104. Cao W, et al. 2017. Immunity. 47:1182. PubMed
  105. Wang C, et al. 2021. Cell Rep. 37:110021. PubMed
  106. Suah AN, et al. 2021. J Clin Invest. 131:. PubMed
  107. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  108. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  109. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  110. Cabrera-Mora M, et al. 2015. Infect Immun . 83: 3749-3761. PubMed
  111. DeBerge M, et al. 2013. PLoS One. 8:79340. PubMed
  112. Fujita Y et al. 2018. Cell reports. 24(12):3296-3311 . PubMed
  113. Samarchith P Kurup et al. 2019. Cell host & microbe. 25(4):565-577 . PubMed
  114. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  115. Lai C, et al. 2009. Invest Ophthalmol Vis Sci. 50:4279. PubMed
  116. MacDonald A, et al. 2021. Front Immunol. 12:755995. PubMed
  117. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  118. Mills C, et al. 2022. Cells. 11:. PubMed
  119. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  120. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  121. Li H, et al. 2022. Theranostics. 12:6422. PubMed
  122. Vijay R, et al. 2015. J Exp Med. 212: 1851 - 1868. PubMed
  123. Mingozzi F, et al. 2016. EMBO Mol Med. 8: 1039 - 1051. PubMed
  124. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  125. Gary EN, et al. 2021. iScience. 24(7):102699. PubMed
  126. Wei JL, et al. 2021. J Immunother Cancer. 9: . PubMed
  127. Harty J 2009. Infect Immun. 77:1894. PubMed
  128. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  129. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  130. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  131. Luo Y et al. 2019. Cell reports. 26(7):1869-1879 . PubMed
  132. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
  133. Snell LM, et al. 2018. Immunity. 49:678. PubMed
  134. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  135. Wang W, et al. 2022. Aging Cell. 21:e13630. PubMed
  136. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  137. Marks KE, et al. 2021. Cell Reports. 35(13):109303. PubMed
  138. Zhu XG, et al. 2020. Cell Metabolism. 33(1):211-221.e6. PubMed
  139. Len-Letelier RA, et al. 2020. Frontiers in Immunology. 11:583382. PubMed
  140. Domeier P, et al. 2016. J Exp Med. 213: 715 - 732. PubMed
  141. Peng Y 2017. PLoS One. 10.1371/journal.pone.0188112. PubMed
  142. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  143. Sinclair LV et al. 2019. Elife. 8 pii: e44210. PubMed
  144. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  145. Kim C, et al. 2019. Cell Rep. 29:2202. PubMed
  146. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  147. Grigoryan L, et al. 2022. NPJ Vaccines. 7:55. PubMed
  148. Bhattacharya D, et al. 2014. J Biol Chem. 289:16508. PubMed
  149. El-Zaatari M, et al. 2014. J Immunol. 193:807. PubMed
  150. Souza COS, et al. 2021. iScience. 24(6):102548. PubMed
  151. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  152. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  153. van Montfoort N, et al. 2018. Cell. 175:1744. PubMed
  154. Park JY, et al. 2019. Cell Rep. 27:2548. PubMed
  155. Malik A et al. 2018. Immunity. 49(3):515-530 . PubMed
  156. Bankoti R, et al. 2017. Sci Rep. 10.1038/s41598-017-12171-3. PubMed
  157. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  158. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  159. Yuan Y, et al. 2022. Cell Rep. 38:110256. PubMed
  160. Takeshita Y, et al. 2021. Neurol Neuroimmunol Neuroinflamm. 8:. PubMed
  161. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  162. Xu Z, et al. 2020. Cancer Immunol Res. 1354:8. PubMed
  163. Harb H, et al. 2021. Immunity. 54(6):1186-1199.e7. PubMed
  164. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  165. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  166. Baban B, et al. 2021. JCI Insight. 6:00. PubMed
  167. Knocke S, et al. 2016. Cell Rep. 17:2234-2246. PubMed
  168. Huang F, et al. 2018. Oncoimmunology. 7:e1450713. PubMed
  169. Levesque S, et al. 2019. Oncoimmunology. 8:e1657375. PubMed
  170. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  171. Matundan HH, et al. 2021. J Virol. 95:e0103621. PubMed
  172. Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
  173. Li YN, et al. 2022. Nat Commun. 13:4074. PubMed
  174. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  175. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  176. Uddback I, et al. 2016. Sci Rep. 6:20137. PubMed
  177. Faust HJ, et al. 2020. J Clin Invest. 130:5493. PubMed
  178. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  179. Tonkin D, et al. 2008. J Immunol. 181:4516. PubMed
  180. Ying Zhang et al. 2017. Cancer cell. 32(3):377-391 . PubMed
  181. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  182. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  183. Dai R, et al. 2021. Front Immunol. 12:727046. PubMed
  184. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  185. Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
  186. Chou T, et al. 2016. Nat Commun. 7:11904. PubMed
  187. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  188. van Vloten JP, et al. 2019. Mol Ther Methods Clin Dev. 13:154. PubMed
  189. Dudeck J, et al. 2019. J Allergy Clin Immunol. 143:1849. PubMed
  190. Montfort M, et al. 2004. J Immunol. 173:4084. PubMed
  191. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  192. Pandit M, et al. 2021. Eur J Immunol. 51:1461. PubMed
  193. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  194. Ma X, et al. 2020. Immunity. 53:1315. PubMed
  195. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  196. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  197. Jin R, et al. 2008. J Immunol. 180:2256. PubMed
  198. Muri J, et al. 2020. eLife. 9:e53627.. PubMed
  199. Gorman JA, et al. 2019. Front Immunol. 10:44. PubMed
  200. Ouyang S, et al. 2019. J Immunol. 202:1441. PubMed
  201. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  202. Wong YC, et al. 2019. J Virol. 93:e01154-19. PubMed
  203. Nenasheva T, et al. 2017. PLoS One. 12(6):e0178983. PubMed
  204. Tajima M, et al. 2022. Curr Protoc. 2:e540. PubMed
  205. Ghorbani S, et al. 2022. Nat Commun. 13:2445. PubMed
  206. Gupta S, et al. 2022. Life Sci. 288:120182. PubMed
  207. Zhang X, et al. 2021. Front Pharmacol. 12:629513. PubMed
  208. Derada Troletti C, et al. 2021. Cell Reports. 35(9):109201. PubMed
  209. Dekhtiarenko I, et al. 2016. PLoS Pathog. 12:e1006072. PubMed
  210. Kang J, Lee J, Chang J 2016. PLoS One. 11: 0157015. PubMed
  211. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
  212. Kang YH, et al. 2019. Nat Commun. 10:912. PubMed
  213. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  214. Wu J, et al. 2021. STAR Protoc. 2:101022. PubMed
  215. Lai Y, et al. 2022. Clin Transl Med. 12:e999. PubMed
  216. Karanika S, et al. 2022. Front Immunol. 13:972266. PubMed
  217. Hartwig S, et al. 2014. PLoS One. 9:90720. PubMed
  218. M H, et al. 2016. Open Bio. 6: 150208. PubMed
  219. Moon J, et al. 2020. Immune Netw. 20:e40. PubMed
  220. Fang Y, et al. 2021. J Clin Invest. 131:00:00. PubMed
  221. Varikuti S, et al. 2020. Br J Cancer. 122:1005. PubMed
  222. Kovacs SB, et al. 2021. STAR Protoc. 2:100244. PubMed
  223. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  224. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  225. Li E, et al. 2021. Front Immunol. 12:667177. PubMed
  226. Lee J, et al. 2007. Nat Immunol. 8:181. PubMed
  227. Liu Y, et al. 2018. Cancer Cell. 33:480. PubMed
  228. Kung YJ, et al. 2022. J Biomed Sci. 29:57. PubMed
  229. Link CWM, et al. 2020. Front Immunol. 11:596772. PubMed
  230. Kurihara T, et al. 2015. PLoS One. 10: e0139692. PubMed
  231. Flesch I, et al. 2015. J Immunol. 195: 2263-2272. PubMed
  232. Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed
  233. Dokoshi T, et al. 2020. Cell Rep. 30:61. PubMed
  234. Renner K, et al. 2020. Cell Reports. 29(1):135-150.e9.. PubMed
  235. Sun Y, et al. 2020. J Immunol. 205:2649. PubMed
  236. Neckermann P, et al. 2021. Front Immunol. 12:761214. PubMed
  237. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  238. Byrne K, et al. 2014. J Immunol. 192:1433. PubMed
  239. Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed
  240. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  241. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  242. Okuyama Y, et al. 2020. FASEB J. 540:34. PubMed
  243. Kwak JE, et al. 2019. Nat Commun. 10:3836. PubMed
  244. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  245. Ding Z, et al. 2017. Sci Rep. 10.1038/s41598-017-12488-z. PubMed
  246. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  247. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  248. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  249. Yang N, et al. 2021. NPJ Precis Oncol. 5:37. PubMed
  250. Tang-Huau TL, et al. 2021. Viruses. 13: . PubMed
  251. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  252. Xu C, et al. 2021. Cell Reports. 35(11):109235. PubMed
  253. Sheng J, et al. 2021. eLife. 10:00. PubMed
  254. Chen S, et al. 2015. Cancer Res . 7: 519-531. PubMed
  255. Bransi A, et al. 2015. Cancer Immunol Res. 3: 1279 - 1288. PubMed
  256. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  257. Steinmann S, et al. 2020. Sci Rep. 1.160416667. PubMed
  258. Yang L, et al. 2021. Front Immunol. 12:722273. PubMed
  259. Schäfer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  260. Tang L, et al. 2022. Front Immunol. 12:770402. PubMed
  261. Li M, et al. 2020. J Immunother Cancer. 8:00. PubMed
  262. Kim SI, et al. 2020. Molecular Cancer Therapeutics. 20(1):173-182. PubMed
  263. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  264. Muri J, et al. 2020. Cell Reports. 30(13):4399-4417. PubMed
  265. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  266. Kalim KW, et al. 2021. Front Immunol. 12:726393. PubMed
  267. Shi GN, et al. 2021. Ther Adv Med Oncol. 13:1758835920987056. PubMed
  268. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  269. Ding X, et al. 2021. Front Immunol. 12:667136. PubMed
  270. Jackson C, et al. 2016. Clin Cancer Res. 22: 1161 - 1172. PubMed
  271. Cignarella F et al. 2018. Cell metabolism. 27(6):1222-1235 . PubMed
  272. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  273. Chinta KC et al. 2018. Cell reports. 25(7):1938-1952 . PubMed
  274. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  275. Zheng X, et al. 2019. PLoS Pathog. 15:e1008036. PubMed
  276. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  277. Hudson WH, et al. 2020. Immunity. 51(6):1043-1058.e4.. PubMed
  278. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  279. Oliver AJ, et al. 2020. Oncoimmunology. 9:1802979. PubMed
  280. Zhou R, et al. 2022. EBioMedicine. 75:103762. PubMed
  281. Zheng J, et al. 2022. Front Pharmacol. 13:866228. PubMed
  282. Tian WJ, et al. 2021. Clin Exp Pharmacol Physiol. 48:902. PubMed
  283. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  284. Xue G, et al. 2021. Cancer Cell. 39:1610. PubMed
  285. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  286. Stone ET, et al. 2022. Cell Rep. 38:110388. PubMed
  287. Guttman O, et al. 2022. J Cell Biol. 221: . PubMed
  288. Qu L, et al. 2022. Cell. 185:1728. PubMed
  289. Grebinoski S, et al. 2022. Nat Immunol. 23:868. PubMed
  290. Guo X, et al. 2022. Invest Ophthalmol Vis Sci. 63:12. PubMed
  291. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  292. Gary EN, et al. 2022. Cell Rep Med. 3:100693. PubMed
  293. Chen C, et al. 2022. Sci Adv. 8:eabo4363. PubMed
  294. Zhang Z, et al. 2022. Mol Nutr Food Res. 66:e2200300. PubMed
  295. Balood M, et al. 2022. Nature. 611:405. PubMed
  296. Zhu M, et al. 2022. Front Immunol. 13:1019248. PubMed
  297. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  298. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  299. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  300. Liu P, et al. 2023. Clin Immunol. 246:109212. PubMed
  301. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  302. Xiao J, et al. 2023. J Clin Invest. 133: . PubMed
  303. Kulkarni R, et al. 2023. Life Sci Alliance. 6: . PubMed
  304. Cheng H, et al. 2023. Nat Metab. 5:314. PubMed
  305. Kemna J, et al. 2023. Nat Immunol. 24:414. PubMed
  306. Vijver SV, et al. 2023. Front Immunol. 13:1100730. PubMed
  307. Drijvers JM, et al. 2021. Cancer Immunol Res. 9:184. PubMed
  308. Jiang L, et al. 2021. Nano Today. 36:. PubMed
  309. Tao X, et al. 2022. J Exp Med. 219:. PubMed
  310. McCafferty S, et al. 2022. Mol Ther. 30:2968. PubMed
  311. Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed
  312. Du J, et al. 2022. Sci Immunol. 7:eabo5407. PubMed
  313. Wang Z, et al. 2022. J Control Release. 349:929. PubMed
  314. Konjar S, et al. 2022. Proc Natl Acad Sci U S A. 119:e2202144119. PubMed
  315. Barsheshet Y, et al. 2022. Int J Mol Sci. 23:. PubMed
  316. Shi X, et al. 2023. iScience. 26:106143. PubMed
  317. Tursi NJ, et al. 2023. Front Immunol. 14:1072810. PubMed
  318. Cheng MI, et al. 2023. Nat Immunol. 24:780. PubMed
  319. Latour YL, et al. 2023. Gut Microbes. 15:2192623. PubMed
  320. Mackin S, et al. 2023. Nat Microbiol. 8:569. PubMed
  321. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  322. Fiedler T, et al. 2023. J Neuroinflammation. 20:100. PubMed
  323. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  324. Seo YB, et al. 2023. Int J Mol Sci. 24:. PubMed
  325. Wang X, et al. 2023. Nat Commun. 14:3440. PubMed
  326. Bergot AS, et al. 2020. J Immunol. 204:1787. PubMed
  327. Quispe Calla N, et al. 2016. Sci Rep. 6:37723. PubMed
  328. Harsha Krovi S, et al. 2020. Nat Commun. 4.790277778. PubMed
  329. Cella M, et al. 2019. Nat Immunol. 1.513888889. PubMed
  330. Xie A et al. 2017. Endocrinology. 158(10):3140-3151 . PubMed
  331. Vacca M, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01462. PubMed
  332. Yang N, et al. 2022. NPJ Vaccines. 7:120. PubMed
  333. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  334. Suresh R, et al. 2020. J Immunother Cancer. 8:. PubMed
  335. Hamilton JAG, et al. 2021. Aging Cell. 20:e13309. PubMed
  336. Du C, et al. 2016. Nat Commun. 7: 11120. PubMed
  337. Yang C, et al. 2018. J Immunol. 200:1316. PubMed
  338. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  339. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  340. Turner JA, et al. 2020. Immunity. 53:1202. PubMed
  341. Wabitsch S, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1166. PubMed
  342. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  343. Muthumani K, et al. 2015. Sci Transl Med. 7: 301ra132. PubMed
  344. Laroche-Lefebvre C, et al. 2016. J Immunol. 197: 3618 - 3627. PubMed
  345. Sanchez-Felipe L, et al. 2021. Nature. 590:320. PubMed
  346. Seo YB, et al. 2021. Vaccines (Basel). 9: . PubMed
  347. Burrack AL, et al. 2019. Cell Rep. 28:2140. PubMed
  348. Li Y, et al. 2020. Cell Rep. 30:1753. PubMed
  349. Ron–Harel N, et al. 2019. Cell Rep. 28:3011. PubMed
  350. Chow MT et al. 2019. Immunity. 50(6):1498-1512 . PubMed
  351. Lu J, et al. 2018. ACS Nano. 12:11041. PubMed
  352. Diao L, et al. 2022. iScience. 25:105511. PubMed
  353. Guo Q, et al. 2021. Front Cardiovasc Med. 8:633212. PubMed
  354. Gu M, et al. 2021. Nat Immunol. 22:193. PubMed
  355. Yang X, et al. 2021. Front Pharmacol. 12:771046. PubMed
  356. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  357. Klarquist J, et al. 2021. Cell Rep. 36:109591. PubMed
  358. Fitzgerald AA, et al. 2021. J Immunother Cancer. 9:. PubMed
  359. Wabitsch S, et al. 2021. STAR Protoc. 2:100517. PubMed
  360. Oda SK, et al. 2020. J Exp Med. 217: . PubMed
  361. Devalaraja S, et al. 2020. Cell. 1098:180. PubMed
  362. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  363. Zhao Y, et al. 2015. PLoS One. 10: 0134797. PubMed
  364. Ogawa C et al. 2018. Cell reports. 25(1):19-28 . PubMed
  365. Qi X, et al. 2019. Nat Commun. 10:2141. PubMed
  366. Matsuoka S, et al. 2019. Haematologica. 105:226. PubMed
  367. Saini V, et al. 2020. Nat Commun. 0.845138889. PubMed
  368. Chaurasiya S, et al. 2020. Oncoimmunology. 9:1729300. PubMed
  369. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  370. Konrath KM, et al. 2022. Cell Rep. 38:110318. PubMed
  371. Nagaoka M, et al. 2014. J Immunol. 193:2812. PubMed
  372. Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed
  373. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  374. Cao W, et al. 2017. Immunity. 47:1182. PubMed
  375. Wang C, et al. 2021. Cell Rep. 37:110021. PubMed
  376. Suah AN, et al. 2021. J Clin Invest. 131:. PubMed
  377. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  378. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  379. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  380. Cabrera-Mora M, et al. 2015. Infect Immun . 83: 3749-3761. PubMed
  381. DeBerge M, et al. 2013. PLoS One. 8:79340. PubMed
  382. Fujita Y et al. 2018. Cell reports. 24(12):3296-3311 . PubMed
  383. Samarchith P Kurup et al. 2019. Cell host & microbe. 25(4):565-577 . PubMed
  384. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  385. Lai C, et al. 2009. Invest Ophthalmol Vis Sci. 50:4279. PubMed
  386. MacDonald A, et al. 2021. Front Immunol. 12:755995. PubMed
  387. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  388. Mills C, et al. 2022. Cells. 11:. PubMed
  389. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  390. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  391. Li H, et al. 2022. Theranostics. 12:6422. PubMed
  392. Vijay R, et al. 2015. J Exp Med. 212: 1851 - 1868. PubMed
  393. Mingozzi F, et al. 2016. EMBO Mol Med. 8: 1039 - 1051. PubMed
  394. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  395. Gary EN, et al. 2021. iScience. 24(7):102699. PubMed
  396. Wei JL, et al. 2021. J Immunother Cancer. 9: . PubMed
  397. Harty J 2009. Infect Immun. 77:1894. PubMed
  398. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  399. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  400. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  401. Luo Y et al. 2019. Cell reports. 26(7):1869-1879 . PubMed
  402. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
  403. Snell LM, et al. 2018. Immunity. 49:678. PubMed
  404. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  405. Wang W, et al. 2022. Aging Cell. 21:e13630. PubMed
  406. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  407. Marks KE, et al. 2021. Cell Reports. 35(13):109303. PubMed
  408. Zhu XG, et al. 2020. Cell Metabolism. 33(1):211-221.e6. PubMed
  409. Len-Letelier RA, et al. 2020. Frontiers in Immunology. 11:583382. PubMed
  410. Domeier P, et al. 2016. J Exp Med. 213: 715 - 732. PubMed
  411. Peng Y 2017. PLoS One. 10.1371/journal.pone.0188112. PubMed
  412. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  413. Sinclair LV et al. 2019. Elife. 8 pii: e44210. PubMed
  414. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  415. Kim C, et al. 2019. Cell Rep. 29:2202. PubMed
  416. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  417. Grigoryan L, et al. 2022. NPJ Vaccines. 7:55. PubMed
  418. Bhattacharya D, et al. 2014. J Biol Chem. 289:16508. PubMed
  419. El-Zaatari M, et al. 2014. J Immunol. 193:807. PubMed
  420. Souza COS, et al. 2021. iScience. 24(6):102548. PubMed
  421. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  422. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  423. van Montfoort N, et al. 2018. Cell. 175:1744. PubMed
  424. Park JY, et al. 2019. Cell Rep. 27:2548. PubMed
  425. Malik A et al. 2018. Immunity. 49(3):515-530 . PubMed
  426. Bankoti R, et al. 2017. Sci Rep. 10.1038/s41598-017-12171-3. PubMed
  427. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  428. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  429. Yuan Y, et al. 2022. Cell Rep. 38:110256. PubMed
  430. Takeshita Y, et al. 2021. Neurol Neuroimmunol Neuroinflamm. 8:. PubMed
  431. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  432. Xu Z, et al. 2020. Cancer Immunol Res. 1354:8. PubMed
  433. Harb H, et al. 2021. Immunity. 54(6):1186-1199.e7. PubMed
  434. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  435. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  436. Baban B, et al. 2021. JCI Insight. 6:00. PubMed
  437. Knocke S, et al. 2016. Cell Rep. 17:2234-2246. PubMed
  438. Huang F, et al. 2018. Oncoimmunology. 7:e1450713. PubMed
  439. Levesque S, et al. 2019. Oncoimmunology. 8:e1657375. PubMed
  440. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  441. Matundan HH, et al. 2021. J Virol. 95:e0103621. PubMed
  442. Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
  443. Li YN, et al. 2022. Nat Commun. 13:4074. PubMed
  444. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  445. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  446. Uddback I, et al. 2016. Sci Rep. 6:20137. PubMed
  447. Faust HJ, et al. 2020. J Clin Invest. 130:5493. PubMed
  448. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  449. Tonkin D, et al. 2008. J Immunol. 181:4516. PubMed
  450. Ying Zhang et al. 2017. Cancer cell. 32(3):377-391 . PubMed
  451. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  452. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  453. Dai R, et al. 2021. Front Immunol. 12:727046. PubMed
  454. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  455. Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
  456. Chou T, et al. 2016. Nat Commun. 7:11904. PubMed
  457. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  458. van Vloten JP, et al. 2019. Mol Ther Methods Clin Dev. 13:154. PubMed
  459. Dudeck J, et al. 2019. J Allergy Clin Immunol. 143:1849. PubMed
  460. Montfort M, et al. 2004. J Immunol. 173:4084. PubMed
  461. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  462. Pandit M, et al. 2021. Eur J Immunol. 51:1461. PubMed
  463. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  464. Ma X, et al. 2020. Immunity. 53:1315. PubMed
  465. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  466. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  467. Jin R, et al. 2008. J Immunol. 180:2256. PubMed
  468. Muri J, et al. 2020. eLife. 9:e53627.. PubMed
  469. Gorman JA, et al. 2019. Front Immunol. 10:44. PubMed
  470. Ouyang S, et al. 2019. J Immunol. 202:1441. PubMed
  471. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  472. Wong YC, et al. 2019. J Virol. 93:e01154-19. PubMed
  473. Nenasheva T, et al. 2017. PLoS One. 12(6):e0178983. PubMed
  474. Tajima M, et al. 2022. Curr Protoc. 2:e540. PubMed
  475. Ghorbani S, et al. 2022. Nat Commun. 13:2445. PubMed
  476. Gupta S, et al. 2022. Life Sci. 288:120182. PubMed
  477. Zhang X, et al. 2021. Front Pharmacol. 12:629513. PubMed
  478. Derada Troletti C, et al. 2021. Cell Reports. 35(9):109201. PubMed
  479. Dekhtiarenko I, et al. 2016. PLoS Pathog. 12:e1006072. PubMed
  480. Kang J, Lee J, Chang J 2016. PLoS One. 11: 0157015. PubMed
  481. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
  482. Kang YH, et al. 2019. Nat Commun. 10:912. PubMed
  483. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  484. Wu J, et al. 2021. STAR Protoc. 2:101022. PubMed
  485. Lai Y, et al. 2022. Clin Transl Med. 12:e999. PubMed
  486. Karanika S, et al. 2022. Front Immunol. 13:972266. PubMed
  487. Hartwig S, et al. 2014. PLoS One. 9:90720. PubMed
  488. M H, et al. 2016. Open Bio. 6: 150208. PubMed
  489. Moon J, et al. 2020. Immune Netw. 20:e40. PubMed
  490. Fang Y, et al. 2021. J Clin Invest. 131:00:00. PubMed
  491. Varikuti S, et al. 2020. Br J Cancer. 122:1005. PubMed
  492. Kovacs SB, et al. 2021. STAR Protoc. 2:100244. PubMed
  493. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  494. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  495. Li E, et al. 2021. Front Immunol. 12:667177. PubMed
  496. Lee J, et al. 2007. Nat Immunol. 8:181. PubMed
  497. Liu Y, et al. 2018. Cancer Cell. 33:480. PubMed
  498. Kung YJ, et al. 2022. J Biomed Sci. 29:57. PubMed
  499. Link CWM, et al. 2020. Front Immunol. 11:596772. PubMed
  500. Kurihara T, et al. 2015. PLoS One. 10: e0139692. PubMed
  501. Flesch I, et al. 2015. J Immunol. 195: 2263-2272. PubMed
  502. Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed
  503. Dokoshi T, et al. 2020. Cell Rep. 30:61. PubMed
  504. Renner K, et al. 2020. Cell Reports. 29(1):135-150.e9.. PubMed
  505. Sun Y, et al. 2020. J Immunol. 205:2649. PubMed
  506. Neckermann P, et al. 2021. Front Immunol. 12:761214. PubMed
  507. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  508. Byrne K, et al. 2014. J Immunol. 192:1433. PubMed
  509. Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed
  510. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  511. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  512. Okuyama Y, et al. 2020. FASEB J. 540:34. PubMed
  513. Kwak JE, et al. 2019. Nat Commun. 10:3836. PubMed
  514. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  515. Ding Z, et al. 2017. Sci Rep. 10.1038/s41598-017-12488-z. PubMed
  516. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  517. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  518. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  519. Yang N, et al. 2021. NPJ Precis Oncol. 5:37. PubMed
  520. Tang-Huau TL, et al. 2021. Viruses. 13: . PubMed
  521. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  522. Xu C, et al. 2021. Cell Reports. 35(11):109235. PubMed
  523. Sheng J, et al. 2021. eLife. 10:00. PubMed
  524. Chen S, et al. 2015. Cancer Res . 7: 519-531. PubMed
  525. Bransi A, et al. 2015. Cancer Immunol Res. 3: 1279 - 1288. PubMed
  526. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  527. Steinmann S, et al. 2020. Sci Rep. 1.160416667. PubMed
  528. Yang L, et al. 2021. Front Immunol. 12:722273. PubMed
  529. Schäfer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  530. Tang L, et al. 2022. Front Immunol. 12:770402. PubMed
  531. Li M, et al. 2020. J Immunother Cancer. 8:00. PubMed
  532. Kim SI, et al. 2020. Molecular Cancer Therapeutics. 20(1):173-182. PubMed
  533. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  534. Muri J, et al. 2020. Cell Reports. 30(13):4399-4417. PubMed
  535. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  536. Kalim KW, et al. 2021. Front Immunol. 12:726393. PubMed
  537. Shi GN, et al. 2021. Ther Adv Med Oncol. 13:1758835920987056. PubMed
  538. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  539. Ding X, et al. 2021. Front Immunol. 12:667136. PubMed
  540. Jackson C, et al. 2016. Clin Cancer Res. 22: 1161 - 1172. PubMed
RRID
AB_315404 (BioLegend Cat. No. 505810)
AB_315403 (BioLegend Cat. No. 505809)

Antigen Details

Structure
Cytokine; dimer; 40-80 kD (Mammalian)
Bioactivity
Antiviral/antiparasitic activities; inhibits proliferation; enhances MHC class I and II expression on APCs
Cell Sources
CD8+ and CD4+ T cells, NK cells
Cell Targets
T cells, B cells, macrophages, NK cells, endothelial cells, fibroblasts
Receptors
IFN-γRα (CDw119) dimerized with IFN-γRβ (AF-1)
Cell Type
Tregs
Biology Area
Cell Biology, Immunology, Neuroinflammation, Neuroscience
Molecular Family
Cytokines/Chemokines
Antigen References

1. Fitzgerald K, et al. Eds. 2001. The Cytokine FactsBook. Academic Press, San Diego.
2. De Maeyer E, et al. 1992. Curr. Opin. Immunol. 4:321.
3. Farrar M, et al. 1993. Annu. Rev. Immunol. 11:571.
4. Gray P, et al. 1987. Lymphokines 13:151.

Regulation
Upregulated by IL-2, FGF-basic, EGF; downregulated by 1-α-25-Dihydroxy vitamin D3, dexamethasone
Gene ID
15978 View all products for this Gene ID
UniProt
View information about IFN-gamma on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All IFN-γ Reagents Request Custom Conjugation
Description Clone Applications
Alexa Fluor® 700 anti-mouse IFN-γ XMG1.2 ICFC
APC/Cyanine7 anti-mouse IFN-γ XMG1.2 ICFC
GoInVivo™ Purified anti-mouse IFN-γ XMG1.2 ELISA Capture,ELISPOT Capture,CyTOF®,Neut,ICFC,IHC,WB
APC/Fire™ 750 anti-mouse IFN-γ XMG1.2 ICFC
APC anti-mouse IFN-γ XMG1.2 ICFC
Biotin anti-mouse IFN-γ XMG1.2 ELISA Detection,ELISPOT Detection,ICFC
FITC anti-mouse IFN-γ XMG1.2 ICFC
PE anti-mouse IFN-γ XMG1.2 ICFC
Purified anti-mouse IFN-γ XMG1.2 ELISA Capture,CyTOF®,IHC,WB
Alexa Fluor® 488 anti-mouse IFN-γ XMG1.2 ICFC
Alexa Fluor® 647 anti-mouse IFN-γ XMG1.2 ICFC
Pacific Blue™ anti-mouse IFN-γ XMG1.2 ICFC
PerCP/Cyanine5.5 anti-mouse IFN-γ XMG1.2 ICFC
PE/Cyanine7 anti-mouse IFN-γ XMG1.2 ICFC
Brilliant Violet 421™ anti-mouse IFN-γ XMG1.2 ICFC
Brilliant Violet 650™ anti-mouse IFN-γ XMG1.2 ICFC
Ultra-LEAF™ Purified anti-mouse IFN-γ XMG1.2 ELISA Capture,ELISPOT Capture,CyTOF®,Neut,ICFC,IHC,WB
Brilliant Violet 711™ anti-mouse IFN-γ XMG1.2 ICFC
Brilliant Violet 785™ anti-mouse IFN-γ XMG1.2 ICFC
Brilliant Violet 605™ anti-mouse IFN-γ XMG1.2 ICFC
Brilliant Violet 510™ anti-mouse IFN-γ XMG1.2 ICFC
Purified anti-mouse IFN-γ (Maxpar® Ready) XMG1.2 ELISA Capture,CyTOF®
PE/Dazzle™ 594 anti-mouse IFN-γ XMG1.2 ICFC
Spark NIR™ 685 anti-mouse IFN-γ XMG1.2 ICFC
Spark UV™ 387 anti-mouse IFN-γ XMG1.2 ICFC
Brilliant Violet 750™ anti-mouse IFN-γ XMG1.2 ICFC
TotalSeq™-C1526 anti-mouse IFN-γ Antibody XMG1.2 ICPG
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
XMG1.2 (See other available formats)
Regulatory Status
RUO
Other Names
Interferon-γ, Immune interferon, Type II interferon, T cell interferon, Macrophage-activating factor (MAF)
Isotype
Rat IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
XMG1dot2_APC_032808
PMA/Ionomycin-stimulated (6hrs) C57BL/6 mouse splenocytes stained with XMG1.2 APC and B220 (RA3-6B2) PE
  • XMG1dot2_APC_032808
    PMA/Ionomycin-stimulated (6hrs) C57BL/6 mouse splenocytes stained with XMG1.2 APC and B220 (RA3-6B2) PE
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
505810 100 µg NOK1089
Check Availability


Need larger quantities of this item?
Request Bulk Quote
505809 25 µg NOK363
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

IFN-γ is a potent multifunctional cytokine which is secreted primarily by activated NK cells and T cells. Originally characterized based on anti-viral activities, IFN-γ also exerts anti-proliferative, immunoregulatory, and proinflammatory activities. IFN-γ can upregulate MHC class I and II antigen expression by antigen-presenting cells.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
E. coli-expressed, recombinant mouse IFN-γ
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The IFN-γ antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

ICFC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

ELISA1-4,11,14 or ELISPOT5 Detection: The biotinylated XMG1.2 antibody is useful as a detection antibody for a sandwich ELISA or ELISPOT assay, when used in conjunction with purified R4-6A2 antibody (Cat. No. 505702/505706) as the capture antibody and recombinant mouse IFN-γ (Cat. No. 575309) as the standard.
ELISA or ELISPOT Capture: The purified XMG1.2 antibody is useful as a capture antibody for a sandwich ELISA or ELISPOT assay, when used in conjunction with biotinylated R4-6A2 antibody (Cat. No. 505704) as the detection antibody and recombinant mouse IFN-γ (Cat. No. 575309) as the standard. The LEAF™ purified antibody is suggested for ELISPOT capture (Cat. No. 505812).
Flow Cytometry7,8,12,13,16: The fluorochrome-labeled XMG1.2 antibody is useful for intracellular immunofluorescent staining and flow cytometric analysis to identify IFN-γ-producing cells within mixed cell populations.
Neutralization1-3,9,10: The XMG1.2 antibody can neutralize the bioactivity of natural or recombinant IFN-γ. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for neutralization of mouse IFN-γ bioactivity in vivo and in vitro (Cat. No. 505812). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 505834) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).
Additional reported applications (for the relevant formats) include: Western blotting, immunohistochemical staining of frozen tissue sections6,22,23, and immunocytochemistry.
Note: For testing mouse IFN-γ in serum, plasma or supernatant, BioLegend's ELISA Max™ Sets (Cat. No. 430801 to 430806) are specially developed and recommended.

Application References
  1. Abrams J, et al. 1992. Immunol. Rev. 127:5. (ELISA, Neut)
  2. Sander B, et al. 1993. J. Immunol. Meth. 166:201. (ELISA, Neut)
  3. Abrams J, et al. 1995. Curr. Prot. Immunol. John Wiley and Sons, New York. Unit 6.20. (ELISA, Neut)
  4. Yang X, et al. 1993. J. Immunoassay 14:129. (ELISA)
  5. Klinman D, et al. 1994. Curr. Prot. Immunol. John Wiley and Sons, New York. Unit 6.19. (ELISPOT)
  6. Sander B, et al. 1991. Immunol. Rev. 119:65. (IHC)
  7. Ferrick D, et al. 1995. Nature 373:255. (FC)
  8. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  9. Peterson KE, et al. 2000. J. Virol. 74:5363. (Neut)
  10. DeKrey GK, et al. 1998. Infect. Immun. 66:827. (Neut)
  11. Dzhagalov I, et al. 2007. J. Immunol. 178:2113. (ELISA)
  12. Lawson BR, et al. 2007. J. Immunol. 178:5366. (FC)
  13. Lee JW, et al. 2006. Nature Immunol. 8:181. (FC) PubMed
  14. Xu G, et al. 2007. J. Immunol. 179:5358. (ELISA) PubMed
  15. Montfort M, et al.2004. J. Immunol. 173:4084. PubMed
  16. Haring JS, et al. 2008. J. Immunol. 180:2855. (FC) PubMed
  17. Jordan JM, et al. 2008. Infect Immun. 76:3717. PubMed
  18. Tonkin DR, et al. 2008. J. Immunol. 181:4516. PubMed
  19. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  20. Cui Y, et al. 2009. Invest. Ophth. Vis. Sci. 50:5811. (FC) PubMed
  21. Mykkanen OT, et al. 2014. PLoS One. 9:114790. PubMed
  22. Yokogawa M, et al. 2013. Mol. Carcinog. 52:760. (IHC)
  23. Mottram PL, et al. 1998. J Immunol. 161:602. (IHC)
Product Citations
  1. Cignarella F et al. 2018. Cell metabolism. 27(6):1222-1235 . PubMed
  2. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  3. Chinta KC et al. 2018. Cell reports. 25(7):1938-1952 . PubMed
  4. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  5. Zheng X, et al. 2019. PLoS Pathog. 15:e1008036. PubMed
  6. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  7. Hudson WH, et al. 2020. Immunity. 51(6):1043-1058.e4.. PubMed
  8. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  9. Oliver AJ, et al. 2020. Oncoimmunology. 9:1802979. PubMed
  10. Zhou R, et al. 2022. EBioMedicine. 75:103762. PubMed
  11. Zheng J, et al. 2022. Front Pharmacol. 13:866228. PubMed
  12. Tian WJ, et al. 2021. Clin Exp Pharmacol Physiol. 48:902. PubMed
  13. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  14. Xue G, et al. 2021. Cancer Cell. 39:1610. PubMed
  15. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  16. Stone ET, et al. 2022. Cell Rep. 38:110388. PubMed
  17. Guttman O, et al. 2022. J Cell Biol. 221: . PubMed
  18. Qu L, et al. 2022. Cell. 185:1728. PubMed
  19. Grebinoski S, et al. 2022. Nat Immunol. 23:868. PubMed
  20. Guo X, et al. 2022. Invest Ophthalmol Vis Sci. 63:12. PubMed
  21. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  22. Gary EN, et al. 2022. Cell Rep Med. 3:100693. PubMed
  23. Chen C, et al. 2022. Sci Adv. 8:eabo4363. PubMed
  24. Zhang Z, et al. 2022. Mol Nutr Food Res. 66:e2200300. PubMed
  25. Balood M, et al. 2022. Nature. 611:405. PubMed
  26. Zhu M, et al. 2022. Front Immunol. 13:1019248. PubMed
  27. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  28. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  29. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  30. Liu P, et al. 2023. Clin Immunol. 246:109212. PubMed
  31. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  32. Xiao J, et al. 2023. J Clin Invest. 133: . PubMed
  33. Kulkarni R, et al. 2023. Life Sci Alliance. 6: . PubMed
  34. Cheng H, et al. 2023. Nat Metab. 5:314. PubMed
  35. Kemna J, et al. 2023. Nat Immunol. 24:414. PubMed
  36. Vijver SV, et al. 2023. Front Immunol. 13:1100730. PubMed
  37. Drijvers JM, et al. 2021. Cancer Immunol Res. 9:184. PubMed
  38. Jiang L, et al. 2021. Nano Today. 36:. PubMed
  39. Tao X, et al. 2022. J Exp Med. 219:. PubMed
  40. McCafferty S, et al. 2022. Mol Ther. 30:2968. PubMed
  41. Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed
  42. Du J, et al. 2022. Sci Immunol. 7:eabo5407. PubMed
  43. Wang Z, et al. 2022. J Control Release. 349:929. PubMed
  44. Konjar S, et al. 2022. Proc Natl Acad Sci U S A. 119:e2202144119. PubMed
  45. Barsheshet Y, et al. 2022. Int J Mol Sci. 23:. PubMed
  46. Shi X, et al. 2023. iScience. 26:106143. PubMed
  47. Tursi NJ, et al. 2023. Front Immunol. 14:1072810. PubMed
  48. Cheng MI, et al. 2023. Nat Immunol. 24:780. PubMed
  49. Latour YL, et al. 2023. Gut Microbes. 15:2192623. PubMed
  50. Mackin S, et al. 2023. Nat Microbiol. 8:569. PubMed
  51. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  52. Fiedler T, et al. 2023. J Neuroinflammation. 20:100. PubMed
  53. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  54. Seo YB, et al. 2023. Int J Mol Sci. 24:. PubMed
  55. Wang X, et al. 2023. Nat Commun. 14:3440. PubMed
  56. Bergot AS, et al. 2020. J Immunol. 204:1787. PubMed
  57. Quispe Calla N, et al. 2016. Sci Rep. 6:37723. PubMed
  58. Harsha Krovi S, et al. 2020. Nat Commun. 4.790277778. PubMed
  59. Cella M, et al. 2019. Nat Immunol. 1.513888889. PubMed
  60. Xie A et al. 2017. Endocrinology. 158(10):3140-3151 . PubMed
  61. Vacca M, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01462. PubMed
  62. Yang N, et al. 2022. NPJ Vaccines. 7:120. PubMed
  63. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  64. Suresh R, et al. 2020. J Immunother Cancer. 8:. PubMed
  65. Hamilton JAG, et al. 2021. Aging Cell. 20:e13309. PubMed
  66. Du C, et al. 2016. Nat Commun. 7: 11120. PubMed
  67. Yang C, et al. 2018. J Immunol. 200:1316. PubMed
  68. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  69. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  70. Turner JA, et al. 2020. Immunity. 53:1202. PubMed
  71. Wabitsch S, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1166. PubMed
  72. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  73. Muthumani K, et al. 2015. Sci Transl Med. 7: 301ra132. PubMed
  74. Laroche-Lefebvre C, et al. 2016. J Immunol. 197: 3618 - 3627. PubMed
  75. Sanchez-Felipe L, et al. 2021. Nature. 590:320. PubMed
  76. Seo YB, et al. 2021. Vaccines (Basel). 9: . PubMed
  77. Burrack AL, et al. 2019. Cell Rep. 28:2140. PubMed
  78. Li Y, et al. 2020. Cell Rep. 30:1753. PubMed
  79. Ron–Harel N, et al. 2019. Cell Rep. 28:3011. PubMed
  80. Chow MT et al. 2019. Immunity. 50(6):1498-1512 . PubMed
  81. Lu J, et al. 2018. ACS Nano. 12:11041. PubMed
  82. Diao L, et al. 2022. iScience. 25:105511. PubMed
  83. Guo Q, et al. 2021. Front Cardiovasc Med. 8:633212. PubMed
  84. Gu M, et al. 2021. Nat Immunol. 22:193. PubMed
  85. Yang X, et al. 2021. Front Pharmacol. 12:771046. PubMed
  86. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  87. Klarquist J, et al. 2021. Cell Rep. 36:109591. PubMed
  88. Fitzgerald AA, et al. 2021. J Immunother Cancer. 9:. PubMed
  89. Wabitsch S, et al. 2021. STAR Protoc. 2:100517. PubMed
  90. Oda SK, et al. 2020. J Exp Med. 217: . PubMed
  91. Devalaraja S, et al. 2020. Cell. 1098:180. PubMed
  92. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  93. Zhao Y, et al. 2015. PLoS One. 10: 0134797. PubMed
  94. Ogawa C et al. 2018. Cell reports. 25(1):19-28 . PubMed
  95. Qi X, et al. 2019. Nat Commun. 10:2141. PubMed
  96. Matsuoka S, et al. 2019. Haematologica. 105:226. PubMed
  97. Saini V, et al. 2020. Nat Commun. 0.845138889. PubMed
  98. Chaurasiya S, et al. 2020. Oncoimmunology. 9:1729300. PubMed
  99. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  100. Konrath KM, et al. 2022. Cell Rep. 38:110318. PubMed
  101. Nagaoka M, et al. 2014. J Immunol. 193:2812. PubMed
  102. Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed
  103. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  104. Cao W, et al. 2017. Immunity. 47:1182. PubMed
  105. Wang C, et al. 2021. Cell Rep. 37:110021. PubMed
  106. Suah AN, et al. 2021. J Clin Invest. 131:. PubMed
  107. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  108. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  109. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  110. Cabrera-Mora M, et al. 2015. Infect Immun . 83: 3749-3761. PubMed
  111. DeBerge M, et al. 2013. PLoS One. 8:79340. PubMed
  112. Fujita Y et al. 2018. Cell reports. 24(12):3296-3311 . PubMed
  113. Samarchith P Kurup et al. 2019. Cell host & microbe. 25(4):565-577 . PubMed
  114. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  115. Lai C, et al. 2009. Invest Ophthalmol Vis Sci. 50:4279. PubMed
  116. MacDonald A, et al. 2021. Front Immunol. 12:755995. PubMed
  117. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  118. Mills C, et al. 2022. Cells. 11:. PubMed
  119. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  120. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  121. Li H, et al. 2022. Theranostics. 12:6422. PubMed
  122. Vijay R, et al. 2015. J Exp Med. 212: 1851 - 1868. PubMed
  123. Mingozzi F, et al. 2016. EMBO Mol Med. 8: 1039 - 1051. PubMed
  124. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  125. Gary EN, et al. 2021. iScience. 24(7):102699. PubMed
  126. Wei JL, et al. 2021. J Immunother Cancer. 9: . PubMed
  127. Harty J 2009. Infect Immun. 77:1894. PubMed
  128. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  129. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  130. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  131. Luo Y et al. 2019. Cell reports. 26(7):1869-1879 . PubMed
  132. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
  133. Snell LM, et al. 2018. Immunity. 49:678. PubMed
  134. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  135. Wang W, et al. 2022. Aging Cell. 21:e13630. PubMed
  136. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  137. Marks KE, et al. 2021. Cell Reports. 35(13):109303. PubMed
  138. Zhu XG, et al. 2020. Cell Metabolism. 33(1):211-221.e6. PubMed
  139. Len-Letelier RA, et al. 2020. Frontiers in Immunology. 11:583382. PubMed
  140. Domeier P, et al. 2016. J Exp Med. 213: 715 - 732. PubMed
  141. Peng Y 2017. PLoS One. 10.1371/journal.pone.0188112. PubMed
  142. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  143. Sinclair LV et al. 2019. Elife. 8 pii: e44210. PubMed
  144. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  145. Kim C, et al. 2019. Cell Rep. 29:2202. PubMed
  146. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  147. Grigoryan L, et al. 2022. NPJ Vaccines. 7:55. PubMed
  148. Bhattacharya D, et al. 2014. J Biol Chem. 289:16508. PubMed
  149. El-Zaatari M, et al. 2014. J Immunol. 193:807. PubMed
  150. Souza COS, et al. 2021. iScience. 24(6):102548. PubMed
  151. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  152. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  153. van Montfoort N, et al. 2018. Cell. 175:1744. PubMed
  154. Park JY, et al. 2019. Cell Rep. 27:2548. PubMed
  155. Malik A et al. 2018. Immunity. 49(3):515-530 . PubMed
  156. Bankoti R, et al. 2017. Sci Rep. 10.1038/s41598-017-12171-3. PubMed
  157. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  158. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  159. Yuan Y, et al. 2022. Cell Rep. 38:110256. PubMed
  160. Takeshita Y, et al. 2021. Neurol Neuroimmunol Neuroinflamm. 8:. PubMed
  161. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  162. Xu Z, et al. 2020. Cancer Immunol Res. 1354:8. PubMed
  163. Harb H, et al. 2021. Immunity. 54(6):1186-1199.e7. PubMed
  164. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  165. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  166. Baban B, et al. 2021. JCI Insight. 6:00. PubMed
  167. Knocke S, et al. 2016. Cell Rep. 17:2234-2246. PubMed
  168. Huang F, et al. 2018. Oncoimmunology. 7:e1450713. PubMed
  169. Levesque S, et al. 2019. Oncoimmunology. 8:e1657375. PubMed
  170. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  171. Matundan HH, et al. 2021. J Virol. 95:e0103621. PubMed
  172. Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
  173. Li YN, et al. 2022. Nat Commun. 13:4074. PubMed
  174. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  175. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  176. Uddback I, et al. 2016. Sci Rep. 6:20137. PubMed
  177. Faust HJ, et al. 2020. J Clin Invest. 130:5493. PubMed
  178. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  179. Tonkin D, et al. 2008. J Immunol. 181:4516. PubMed
  180. Ying Zhang et al. 2017. Cancer cell. 32(3):377-391 . PubMed
  181. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  182. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  183. Dai R, et al. 2021. Front Immunol. 12:727046. PubMed
  184. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  185. Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
  186. Chou T, et al. 2016. Nat Commun. 7:11904. PubMed
  187. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  188. van Vloten JP, et al. 2019. Mol Ther Methods Clin Dev. 13:154. PubMed
  189. Dudeck J, et al. 2019. J Allergy Clin Immunol. 143:1849. PubMed
  190. Montfort M, et al. 2004. J Immunol. 173:4084. PubMed
  191. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  192. Pandit M, et al. 2021. Eur J Immunol. 51:1461. PubMed
  193. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  194. Ma X, et al. 2020. Immunity. 53:1315. PubMed
  195. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  196. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  197. Jin R, et al. 2008. J Immunol. 180:2256. PubMed
  198. Muri J, et al. 2020. eLife. 9:e53627.. PubMed
  199. Gorman JA, et al. 2019. Front Immunol. 10:44. PubMed
  200. Ouyang S, et al. 2019. J Immunol. 202:1441. PubMed
  201. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  202. Wong YC, et al. 2019. J Virol. 93:e01154-19. PubMed
  203. Nenasheva T, et al. 2017. PLoS One. 12(6):e0178983. PubMed
  204. Tajima M, et al. 2022. Curr Protoc. 2:e540. PubMed
  205. Ghorbani S, et al. 2022. Nat Commun. 13:2445. PubMed
  206. Gupta S, et al. 2022. Life Sci. 288:120182. PubMed
  207. Zhang X, et al. 2021. Front Pharmacol. 12:629513. PubMed
  208. Derada Troletti C, et al. 2021. Cell Reports. 35(9):109201. PubMed
  209. Dekhtiarenko I, et al. 2016. PLoS Pathog. 12:e1006072. PubMed
  210. Kang J, Lee J, Chang J 2016. PLoS One. 11: 0157015. PubMed
  211. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
  212. Kang YH, et al. 2019. Nat Commun. 10:912. PubMed
  213. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  214. Wu J, et al. 2021. STAR Protoc. 2:101022. PubMed
  215. Lai Y, et al. 2022. Clin Transl Med. 12:e999. PubMed
  216. Karanika S, et al. 2022. Front Immunol. 13:972266. PubMed
  217. Hartwig S, et al. 2014. PLoS One. 9:90720. PubMed
  218. M H, et al. 2016. Open Bio. 6: 150208. PubMed
  219. Moon J, et al. 2020. Immune Netw. 20:e40. PubMed
  220. Fang Y, et al. 2021. J Clin Invest. 131:00:00. PubMed
  221. Varikuti S, et al. 2020. Br J Cancer. 122:1005. PubMed
  222. Kovacs SB, et al. 2021. STAR Protoc. 2:100244. PubMed
  223. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  224. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  225. Li E, et al. 2021. Front Immunol. 12:667177. PubMed
  226. Lee J, et al. 2007. Nat Immunol. 8:181. PubMed
  227. Liu Y, et al. 2018. Cancer Cell. 33:480. PubMed
  228. Kung YJ, et al. 2022. J Biomed Sci. 29:57. PubMed
  229. Link CWM, et al. 2020. Front Immunol. 11:596772. PubMed
  230. Kurihara T, et al. 2015. PLoS One. 10: e0139692. PubMed
  231. Flesch I, et al. 2015. J Immunol. 195: 2263-2272. PubMed
  232. Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed
  233. Dokoshi T, et al. 2020. Cell Rep. 30:61. PubMed
  234. Renner K, et al. 2020. Cell Reports. 29(1):135-150.e9.. PubMed
  235. Sun Y, et al. 2020. J Immunol. 205:2649. PubMed
  236. Neckermann P, et al. 2021. Front Immunol. 12:761214. PubMed
  237. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  238. Byrne K, et al. 2014. J Immunol. 192:1433. PubMed
  239. Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed
  240. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  241. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  242. Okuyama Y, et al. 2020. FASEB J. 540:34. PubMed
  243. Kwak JE, et al. 2019. Nat Commun. 10:3836. PubMed
  244. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  245. Ding Z, et al. 2017. Sci Rep. 10.1038/s41598-017-12488-z. PubMed
  246. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  247. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  248. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  249. Yang N, et al. 2021. NPJ Precis Oncol. 5:37. PubMed
  250. Tang-Huau TL, et al. 2021. Viruses. 13: . PubMed
  251. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  252. Xu C, et al. 2021. Cell Reports. 35(11):109235. PubMed
  253. Sheng J, et al. 2021. eLife. 10:00. PubMed
  254. Chen S, et al. 2015. Cancer Res . 7: 519-531. PubMed
  255. Bransi A, et al. 2015. Cancer Immunol Res. 3: 1279 - 1288. PubMed
  256. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  257. Steinmann S, et al. 2020. Sci Rep. 1.160416667. PubMed
  258. Yang L, et al. 2021. Front Immunol. 12:722273. PubMed
  259. Schäfer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  260. Tang L, et al. 2022. Front Immunol. 12:770402. PubMed
  261. Li M, et al. 2020. J Immunother Cancer. 8:00. PubMed
  262. Kim SI, et al. 2020. Molecular Cancer Therapeutics. 20(1):173-182. PubMed
  263. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  264. Muri J, et al. 2020. Cell Reports. 30(13):4399-4417. PubMed
  265. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  266. Kalim KW, et al. 2021. Front Immunol. 12:726393. PubMed
  267. Shi GN, et al. 2021. Ther Adv Med Oncol. 13:1758835920987056. PubMed
  268. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  269. Ding X, et al. 2021. Front Immunol. 12:667136. PubMed
  270. Jackson C, et al. 2016. Clin Cancer Res. 22: 1161 - 1172. PubMed
  271. Cignarella F et al. 2018. Cell metabolism. 27(6):1222-1235 . PubMed
  272. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  273. Chinta KC et al. 2018. Cell reports. 25(7):1938-1952 . PubMed
  274. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  275. Zheng X, et al. 2019. PLoS Pathog. 15:e1008036. PubMed
  276. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  277. Hudson WH, et al. 2020. Immunity. 51(6):1043-1058.e4.. PubMed
  278. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  279. Oliver AJ, et al. 2020. Oncoimmunology. 9:1802979. PubMed
  280. Zhou R, et al. 2022. EBioMedicine. 75:103762. PubMed
  281. Zheng J, et al. 2022. Front Pharmacol. 13:866228. PubMed
  282. Tian WJ, et al. 2021. Clin Exp Pharmacol Physiol. 48:902. PubMed
  283. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  284. Xue G, et al. 2021. Cancer Cell. 39:1610. PubMed
  285. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  286. Stone ET, et al. 2022. Cell Rep. 38:110388. PubMed
  287. Guttman O, et al. 2022. J Cell Biol. 221: . PubMed
  288. Qu L, et al. 2022. Cell. 185:1728. PubMed
  289. Grebinoski S, et al. 2022. Nat Immunol. 23:868. PubMed
  290. Guo X, et al. 2022. Invest Ophthalmol Vis Sci. 63:12. PubMed
  291. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  292. Gary EN, et al. 2022. Cell Rep Med. 3:100693. PubMed
  293. Chen C, et al. 2022. Sci Adv. 8:eabo4363. PubMed
  294. Zhang Z, et al. 2022. Mol Nutr Food Res. 66:e2200300. PubMed
  295. Balood M, et al. 2022. Nature. 611:405. PubMed
  296. Zhu M, et al. 2022. Front Immunol. 13:1019248. PubMed
  297. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  298. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  299. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  300. Liu P, et al. 2023. Clin Immunol. 246:109212. PubMed
  301. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  302. Xiao J, et al. 2023. J Clin Invest. 133: . PubMed
  303. Kulkarni R, et al. 2023. Life Sci Alliance. 6: . PubMed
  304. Cheng H, et al. 2023. Nat Metab. 5:314. PubMed
  305. Kemna J, et al. 2023. Nat Immunol. 24:414. PubMed
  306. Vijver SV, et al. 2023. Front Immunol. 13:1100730. PubMed
  307. Drijvers JM, et al. 2021. Cancer Immunol Res. 9:184. PubMed
  308. Jiang L, et al. 2021. Nano Today. 36:. PubMed
  309. Tao X, et al. 2022. J Exp Med. 219:. PubMed
  310. McCafferty S, et al. 2022. Mol Ther. 30:2968. PubMed
  311. Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed
  312. Du J, et al. 2022. Sci Immunol. 7:eabo5407. PubMed
  313. Wang Z, et al. 2022. J Control Release. 349:929. PubMed
  314. Konjar S, et al. 2022. Proc Natl Acad Sci U S A. 119:e2202144119. PubMed
  315. Barsheshet Y, et al. 2022. Int J Mol Sci. 23:. PubMed
  316. Shi X, et al. 2023. iScience. 26:106143. PubMed
  317. Tursi NJ, et al. 2023. Front Immunol. 14:1072810. PubMed
  318. Cheng MI, et al. 2023. Nat Immunol. 24:780. PubMed
  319. Latour YL, et al. 2023. Gut Microbes. 15:2192623. PubMed
  320. Mackin S, et al. 2023. Nat Microbiol. 8:569. PubMed
  321. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  322. Fiedler T, et al. 2023. J Neuroinflammation. 20:100. PubMed
  323. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  324. Seo YB, et al. 2023. Int J Mol Sci. 24:. PubMed
  325. Wang X, et al. 2023. Nat Commun. 14:3440. PubMed
  326. Bergot AS, et al. 2020. J Immunol. 204:1787. PubMed
  327. Quispe Calla N, et al. 2016. Sci Rep. 6:37723. PubMed
  328. Harsha Krovi S, et al. 2020. Nat Commun. 4.790277778. PubMed
  329. Cella M, et al. 2019. Nat Immunol. 1.513888889. PubMed
  330. Xie A et al. 2017. Endocrinology. 158(10):3140-3151 . PubMed
  331. Vacca M, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01462. PubMed
  332. Yang N, et al. 2022. NPJ Vaccines. 7:120. PubMed
  333. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  334. Suresh R, et al. 2020. J Immunother Cancer. 8:. PubMed
  335. Hamilton JAG, et al. 2021. Aging Cell. 20:e13309. PubMed
  336. Du C, et al. 2016. Nat Commun. 7: 11120. PubMed
  337. Yang C, et al. 2018. J Immunol. 200:1316. PubMed
  338. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  339. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  340. Turner JA, et al. 2020. Immunity. 53:1202. PubMed
  341. Wabitsch S, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1166. PubMed
  342. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  343. Muthumani K, et al. 2015. Sci Transl Med. 7: 301ra132. PubMed
  344. Laroche-Lefebvre C, et al. 2016. J Immunol. 197: 3618 - 3627. PubMed
  345. Sanchez-Felipe L, et al. 2021. Nature. 590:320. PubMed
  346. Seo YB, et al. 2021. Vaccines (Basel). 9: . PubMed
  347. Burrack AL, et al. 2019. Cell Rep. 28:2140. PubMed
  348. Li Y, et al. 2020. Cell Rep. 30:1753. PubMed
  349. Ron–Harel N, et al. 2019. Cell Rep. 28:3011. PubMed
  350. Chow MT et al. 2019. Immunity. 50(6):1498-1512 . PubMed
  351. Lu J, et al. 2018. ACS Nano. 12:11041. PubMed
  352. Diao L, et al. 2022. iScience. 25:105511. PubMed
  353. Guo Q, et al. 2021. Front Cardiovasc Med. 8:633212. PubMed
  354. Gu M, et al. 2021. Nat Immunol. 22:193. PubMed
  355. Yang X, et al. 2021. Front Pharmacol. 12:771046. PubMed
  356. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  357. Klarquist J, et al. 2021. Cell Rep. 36:109591. PubMed
  358. Fitzgerald AA, et al. 2021. J Immunother Cancer. 9:. PubMed
  359. Wabitsch S, et al. 2021. STAR Protoc. 2:100517. PubMed
  360. Oda SK, et al. 2020. J Exp Med. 217: . PubMed
  361. Devalaraja S, et al. 2020. Cell. 1098:180. PubMed
  362. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  363. Zhao Y, et al. 2015. PLoS One. 10: 0134797. PubMed
  364. Ogawa C et al. 2018. Cell reports. 25(1):19-28 . PubMed
  365. Qi X, et al. 2019. Nat Commun. 10:2141. PubMed
  366. Matsuoka S, et al. 2019. Haematologica. 105:226. PubMed
  367. Saini V, et al. 2020. Nat Commun. 0.845138889. PubMed
  368. Chaurasiya S, et al. 2020. Oncoimmunology. 9:1729300. PubMed
  369. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  370. Konrath KM, et al. 2022. Cell Rep. 38:110318. PubMed
  371. Nagaoka M, et al. 2014. J Immunol. 193:2812. PubMed
  372. Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed
  373. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  374. Cao W, et al. 2017. Immunity. 47:1182. PubMed
  375. Wang C, et al. 2021. Cell Rep. 37:110021. PubMed
  376. Suah AN, et al. 2021. J Clin Invest. 131:. PubMed
  377. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  378. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  379. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  380. Cabrera-Mora M, et al. 2015. Infect Immun . 83: 3749-3761. PubMed
  381. DeBerge M, et al. 2013. PLoS One. 8:79340. PubMed
  382. Fujita Y et al. 2018. Cell reports. 24(12):3296-3311 . PubMed
  383. Samarchith P Kurup et al. 2019. Cell host & microbe. 25(4):565-577 . PubMed
  384. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  385. Lai C, et al. 2009. Invest Ophthalmol Vis Sci. 50:4279. PubMed
  386. MacDonald A, et al. 2021. Front Immunol. 12:755995. PubMed
  387. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  388. Mills C, et al. 2022. Cells. 11:. PubMed
  389. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  390. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  391. Li H, et al. 2022. Theranostics. 12:6422. PubMed
  392. Vijay R, et al. 2015. J Exp Med. 212: 1851 - 1868. PubMed
  393. Mingozzi F, et al. 2016. EMBO Mol Med. 8: 1039 - 1051. PubMed
  394. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  395. Gary EN, et al. 2021. iScience. 24(7):102699. PubMed
  396. Wei JL, et al. 2021. J Immunother Cancer. 9: . PubMed
  397. Harty J 2009. Infect Immun. 77:1894. PubMed
  398. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  399. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  400. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  401. Luo Y et al. 2019. Cell reports. 26(7):1869-1879 . PubMed
  402. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
  403. Snell LM, et al. 2018. Immunity. 49:678. PubMed
  404. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  405. Wang W, et al. 2022. Aging Cell. 21:e13630. PubMed
  406. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  407. Marks KE, et al. 2021. Cell Reports. 35(13):109303. PubMed
  408. Zhu XG, et al. 2020. Cell Metabolism. 33(1):211-221.e6. PubMed
  409. Len-Letelier RA, et al. 2020. Frontiers in Immunology. 11:583382. PubMed
  410. Domeier P, et al. 2016. J Exp Med. 213: 715 - 732. PubMed
  411. Peng Y 2017. PLoS One. 10.1371/journal.pone.0188112. PubMed
  412. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  413. Sinclair LV et al. 2019. Elife. 8 pii: e44210. PubMed
  414. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  415. Kim C, et al. 2019. Cell Rep. 29:2202. PubMed
  416. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  417. Grigoryan L, et al. 2022. NPJ Vaccines. 7:55. PubMed
  418. Bhattacharya D, et al. 2014. J Biol Chem. 289:16508. PubMed
  419. El-Zaatari M, et al. 2014. J Immunol. 193:807. PubMed
  420. Souza COS, et al. 2021. iScience. 24(6):102548. PubMed
  421. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  422. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  423. van Montfoort N, et al. 2018. Cell. 175:1744. PubMed
  424. Park JY, et al. 2019. Cell Rep. 27:2548. PubMed
  425. Malik A et al. 2018. Immunity. 49(3):515-530 . PubMed
  426. Bankoti R, et al. 2017. Sci Rep. 10.1038/s41598-017-12171-3. PubMed
  427. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  428. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  429. Yuan Y, et al. 2022. Cell Rep. 38:110256. PubMed
  430. Takeshita Y, et al. 2021. Neurol Neuroimmunol Neuroinflamm. 8:. PubMed
  431. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  432. Xu Z, et al. 2020. Cancer Immunol Res. 1354:8. PubMed
  433. Harb H, et al. 2021. Immunity. 54(6):1186-1199.e7. PubMed
  434. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  435. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  436. Baban B, et al. 2021. JCI Insight. 6:00. PubMed
  437. Knocke S, et al. 2016. Cell Rep. 17:2234-2246. PubMed
  438. Huang F, et al. 2018. Oncoimmunology. 7:e1450713. PubMed
  439. Levesque S, et al. 2019. Oncoimmunology. 8:e1657375. PubMed
  440. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  441. Matundan HH, et al. 2021. J Virol. 95:e0103621. PubMed
  442. Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
  443. Li YN, et al. 2022. Nat Commun. 13:4074. PubMed
  444. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  445. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  446. Uddback I, et al. 2016. Sci Rep. 6:20137. PubMed
  447. Faust HJ, et al. 2020. J Clin Invest. 130:5493. PubMed
  448. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  449. Tonkin D, et al. 2008. J Immunol. 181:4516. PubMed
  450. Ying Zhang et al. 2017. Cancer cell. 32(3):377-391 . PubMed
  451. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  452. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  453. Dai R, et al. 2021. Front Immunol. 12:727046. PubMed
  454. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  455. Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
  456. Chou T, et al. 2016. Nat Commun. 7:11904. PubMed
  457. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  458. van Vloten JP, et al. 2019. Mol Ther Methods Clin Dev. 13:154. PubMed
  459. Dudeck J, et al. 2019. J Allergy Clin Immunol. 143:1849. PubMed
  460. Montfort M, et al. 2004. J Immunol. 173:4084. PubMed
  461. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  462. Pandit M, et al. 2021. Eur J Immunol. 51:1461. PubMed
  463. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  464. Ma X, et al. 2020. Immunity. 53:1315. PubMed
  465. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  466. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  467. Jin R, et al. 2008. J Immunol. 180:2256. PubMed
  468. Muri J, et al. 2020. eLife. 9:e53627.. PubMed
  469. Gorman JA, et al. 2019. Front Immunol. 10:44. PubMed
  470. Ouyang S, et al. 2019. J Immunol. 202:1441. PubMed
  471. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  472. Wong YC, et al. 2019. J Virol. 93:e01154-19. PubMed
  473. Nenasheva T, et al. 2017. PLoS One. 12(6):e0178983. PubMed
  474. Tajima M, et al. 2022. Curr Protoc. 2:e540. PubMed
  475. Ghorbani S, et al. 2022. Nat Commun. 13:2445. PubMed
  476. Gupta S, et al. 2022. Life Sci. 288:120182. PubMed
  477. Zhang X, et al. 2021. Front Pharmacol. 12:629513. PubMed
  478. Derada Troletti C, et al. 2021. Cell Reports. 35(9):109201. PubMed
  479. Dekhtiarenko I, et al. 2016. PLoS Pathog. 12:e1006072. PubMed
  480. Kang J, Lee J, Chang J 2016. PLoS One. 11: 0157015. PubMed
  481. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
  482. Kang YH, et al. 2019. Nat Commun. 10:912. PubMed
  483. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  484. Wu J, et al. 2021. STAR Protoc. 2:101022. PubMed
  485. Lai Y, et al. 2022. Clin Transl Med. 12:e999. PubMed
  486. Karanika S, et al. 2022. Front Immunol. 13:972266. PubMed
  487. Hartwig S, et al. 2014. PLoS One. 9:90720. PubMed
  488. M H, et al. 2016. Open Bio. 6: 150208. PubMed
  489. Moon J, et al. 2020. Immune Netw. 20:e40. PubMed
  490. Fang Y, et al. 2021. J Clin Invest. 131:00:00. PubMed
  491. Varikuti S, et al. 2020. Br J Cancer. 122:1005. PubMed
  492. Kovacs SB, et al. 2021. STAR Protoc. 2:100244. PubMed
  493. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  494. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  495. Li E, et al. 2021. Front Immunol. 12:667177. PubMed
  496. Lee J, et al. 2007. Nat Immunol. 8:181. PubMed
  497. Liu Y, et al. 2018. Cancer Cell. 33:480. PubMed
  498. Kung YJ, et al. 2022. J Biomed Sci. 29:57. PubMed
  499. Link CWM, et al. 2020. Front Immunol. 11:596772. PubMed
  500. Kurihara T, et al. 2015. PLoS One. 10: e0139692. PubMed
  501. Flesch I, et al. 2015. J Immunol. 195: 2263-2272. PubMed
  502. Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed
  503. Dokoshi T, et al. 2020. Cell Rep. 30:61. PubMed
  504. Renner K, et al. 2020. Cell Reports. 29(1):135-150.e9.. PubMed
  505. Sun Y, et al. 2020. J Immunol. 205:2649. PubMed
  506. Neckermann P, et al. 2021. Front Immunol. 12:761214. PubMed
  507. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  508. Byrne K, et al. 2014. J Immunol. 192:1433. PubMed
  509. Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed
  510. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  511. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  512. Okuyama Y, et al. 2020. FASEB J. 540:34. PubMed
  513. Kwak JE, et al. 2019. Nat Commun. 10:3836. PubMed
  514. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  515. Ding Z, et al. 2017. Sci Rep. 10.1038/s41598-017-12488-z. PubMed
  516. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  517. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  518. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  519. Yang N, et al. 2021. NPJ Precis Oncol. 5:37. PubMed
  520. Tang-Huau TL, et al. 2021. Viruses. 13: . PubMed
  521. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  522. Xu C, et al. 2021. Cell Reports. 35(11):109235. PubMed
  523. Sheng J, et al. 2021. eLife. 10:00. PubMed
  524. Chen S, et al. 2015. Cancer Res . 7: 519-531. PubMed
  525. Bransi A, et al. 2015. Cancer Immunol Res. 3: 1279 - 1288. PubMed
  526. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  527. Steinmann S, et al. 2020. Sci Rep. 1.160416667. PubMed
  528. Yang L, et al. 2021. Front Immunol. 12:722273. PubMed
  529. Schäfer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  530. Tang L, et al. 2022. Front Immunol. 12:770402. PubMed
  531. Li M, et al. 2020. J Immunother Cancer. 8:00. PubMed
  532. Kim SI, et al. 2020. Molecular Cancer Therapeutics. 20(1):173-182. PubMed
  533. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  534. Muri J, et al. 2020. Cell Reports. 30(13):4399-4417. PubMed
  535. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  536. Kalim KW, et al. 2021. Front Immunol. 12:726393. PubMed
  537. Shi GN, et al. 2021. Ther Adv Med Oncol. 13:1758835920987056. PubMed
  538. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  539. Ding X, et al. 2021. Front Immunol. 12:667136. PubMed
  540. Jackson C, et al. 2016. Clin Cancer Res. 22: 1161 - 1172. PubMed
RRID
AB_315404 (BioLegend Cat. No. 505810)
AB_315403 (BioLegend Cat. No. 505809)

Antigen Details

Structure
Cytokine; dimer; 40-80 kD (Mammalian)
Bioactivity
Antiviral/antiparasitic activities; inhibits proliferation; enhances MHC class I and II expression on APCs
Cell Sources
CD8+ and CD4+ T cells, NK cells
Cell Targets
T cells, B cells, macrophages, NK cells, endothelial cells, fibroblasts
Receptors
IFN-γRα (CDw119) dimerized with IFN-γRβ (AF-1)
Cell Type
Tregs
Biology Area
Cell Biology, Immunology, Neuroinflammation, Neuroscience
Molecular Family
Cytokines/Chemokines
Antigen References

1. Fitzgerald K, et al. Eds. 2001. The Cytokine FactsBook. Academic Press, San Diego.
2. De Maeyer E, et al. 1992. Curr. Opin. Immunol. 4:321.
3. Farrar M, et al. 1993. Annu. Rev. Immunol. 11:571.
4. Gray P, et al. 1987. Lymphokines 13:151.

Regulation
Upregulated by IL-2, FGF-basic, EGF; downregulated by 1-α-25-Dihydroxy vitamin D3, dexamethasone
Gene ID
15978 View all products for this Gene ID
UniProt
View information about IFN-gamma on UniProt.org

Other Formats

View All IFN-γ Reagents Request Custom Conjugation
Description Clone Applications
Alexa Fluor® 700 anti-mouse IFN-γ XMG1.2 ICFC
APC/Cyanine7 anti-mouse IFN-γ XMG1.2 ICFC
GoInVivo™ Purified anti-mouse IFN-γ XMG1.2 ELISA Capture,ELISPOT Capture,CyTOF®,Neut,ICFC,IHC,WB
APC/Fire™ 750 anti-mouse IFN-γ XMG1.2 ICFC
APC anti-mouse IFN-γ XMG1.2 ICFC
Biotin anti-mouse IFN-γ XMG1.2 ELISA Detection,ELISPOT Detection,ICFC
FITC anti-mouse IFN-γ XMG1.2 ICFC
PE anti-mouse IFN-γ XMG1.2 ICFC
Purified anti-mouse IFN-γ XMG1.2 ELISA Capture,CyTOF®,IHC,WB
Alexa Fluor® 488 anti-mouse IFN-γ XMG1.2 ICFC
Alexa Fluor® 647 anti-mouse IFN-γ XMG1.2 ICFC
Pacific Blue™ anti-mouse IFN-γ XMG1.2 ICFC
PerCP/Cyanine5.5 anti-mouse IFN-γ XMG1.2 ICFC
PE/Cyanine7 anti-mouse IFN-γ XMG1.2 ICFC
Brilliant Violet 421™ anti-mouse IFN-γ XMG1.2 ICFC
Brilliant Violet 650™ anti-mouse IFN-γ XMG1.2 ICFC
Ultra-LEAF™ Purified anti-mouse IFN-γ XMG1.2 ELISA Capture,ELISPOT Capture,CyTOF®,Neut,ICFC,IHC,WB
Brilliant Violet 711™ anti-mouse IFN-γ XMG1.2 ICFC
Brilliant Violet 785™ anti-mouse IFN-γ XMG1.2 ICFC
Brilliant Violet 605™ anti-mouse IFN-γ XMG1.2 ICFC
Brilliant Violet 510™ anti-mouse IFN-γ XMG1.2 ICFC
Purified anti-mouse IFN-γ (Maxpar® Ready) XMG1.2 ELISA Capture,CyTOF®
PE/Dazzle™ 594 anti-mouse IFN-γ XMG1.2 ICFC
Spark NIR™ 685 anti-mouse IFN-γ XMG1.2 ICFC
Spark UV™ 387 anti-mouse IFN-γ XMG1.2 ICFC
Brilliant Violet 750™ anti-mouse IFN-γ XMG1.2 ICFC
TotalSeq™-C1526 anti-mouse IFN-γ Antibody XMG1.2 ICPG
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account